Neonatal cancer cells promote platelet production and activation by secreting active substances such as interleukin-6, while activated platelets secrete vascular endothelial growth factor, platelet-derived growth factor, and transforming growth factor-β to promote cancer angiogenesis [45–47]. This evidence concerns the gene IL6 and cancer.